Parallax Volatility Advisers’s Insmed INSM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-200
Closed -$28.8K 1737
2025
Q3
$28.8K Hold
200
﹤0.01% 1498
2025
Q2
$20.1K Hold
200
﹤0.01% 1475
2025
Q1
$15.3K Hold
200
﹤0.01% 1421
2024
Q4
$13.8K Sell
200
-100
-33% -$7.2K ﹤0.01% 1854
2024
Q3
$21.9K Sell
300
-100
-25% -$7.38K ﹤0.01% 1893
2024
Q2
$26.8K Sell
400
-7,900
-95% -$306K ﹤0.01% 1808
2024
Q1
$225K Buy
8,300
+6,300
+315% +$176K ﹤0.01% 1533
2023
Q4
$62K Sell
2,000
-38,000
-95% -$985K ﹤0.01% 1904
2023
Q3
$1.01M Buy
+40,000
New +$915K ﹤0.01% 1363
2022
Q4
Sell
-14,200
Closed -$305K 3063
2022
Q3
$305K Buy
+14,200
New +$340K ﹤0.01% 2166
2019
Q2
Sell
-12,000
Closed -$349K 3143
2019
Q1
$349K Sell
12,000
-6,000
-33% -$156K ﹤0.01% 1660
2018
Q4
$236K Hold
18,000
﹤0.01% 1706
2018
Q3
$364K Hold
18,000
﹤0.01% 1509
2018
Q2
$426K Buy
+18,000
New +$463K ﹤0.01% 1298

Other funds holding INSM

Parallax Volatility Advisers's INSM Position: Q1 2026 in Review

Parallax Volatility Advisers reduced its Insmed (INSM) stake by 92% in Q1 2026, selling an estimated $268K and leaving 150 shares worth $21.1K. The position accounts for ﹤0.01% of the portfolio, ranked #1326.

Parallax Volatility Advisers first reported a position in INSM in Q2 2014 and has held it in 16 quarters since. The position peaked at $12.3M in Q2 2024. 670 funds tracked by Wall St. Rank hold INSM as of Q1 2026.

  • Parallax Volatility Advisers held 150 shares of Insmed worth $21.1K as of Q1 2026.
  • Parallax Volatility Advisers sold 1,740 Insmed shares in Q1 2026, an estimated $268K.
  • Insmed made up ﹤0.01% of Parallax Volatility Advisers's portfolio in Q1 2026, its #1326 holding.
  • Parallax Volatility Advisers first reported a position in Insmed in Q2 2014 and has held it in 16 quarters since.
  • Parallax Volatility Advisers's Insmed position peaked at $12.3M in Q2 2024.
  • 670 funds tracked by Wall St. Rank held Insmed as of Q1 2026.

Based on Parallax Volatility Advisers's 13F filing for Q1 2026, filed 15 May 2026.